Rachel C. Fleck

This study identifies immune signatures in mice and human urine that predict preterm birth risk following UTI, highlighting cytokines like IL-10 and IL-15 as potential therapeutic targets.

This study characterizes Pseudomonas aeruginosa as an emerging uropathogen in UTIs, identifying antibiotic resistance patterns, virulence factors, and associations with patient demographics and catheter use.

This study develops human bladder organoids to model UTIs and phage therapy, showing phage reduces bacterial loads and inflammation during infection.